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PUsefulness of Virtual Histology Intravascular
Ultrasound to Predict Distal Embolization
for ST-Segment Elevation Myocardial Infarction
Ren Kawaguchi, MD, Shigeru Oshima, MD, PHD, Masaaki Jingu, RT, Hideki Tsurugaya, MD,
Takuji Toyama, MD, PHD, Hiroshi Hoshizaki, MD, PHD, Koichi Taniguchi, MD, PHD
Gunma, Japan
Objectives We aimed to predict the high-risk plaque of distal embolization after stent deployment in patients with acute
ST-segment elevation myocardial infarction (STEMI) with Virtual Histology intravascular ultrasound (VH-IVUS) (Vol-
cano Therapeutics, Inc., Rancho Cordova, California).
Background Distal embolization during primary percutaneous coronary intervention (PCI) carries a poor prognosis in patients
with STEMI. However, it is unclear which plaque characteristics cause distal embolization after stent deployment.
Methods A total of 71 patients with STEMI were included prospectively. All patients underwent primary PCI within 12 h of
symptom onset. After crossing the lesion with a guidewire and performing thrombectomy with an aspiration
catheter, VH-IVUS of the infarct-related vessel was performed. Stent deployment was then undertaken without
embolic protection. ST-segment re-elevation (STR) was used to evaluate distal embolization. Correlations among
plaque characteristics, morphology, and distal embolization were analyzed.
Results The STR after stent deployment was observed in 11 patients (STR group, 15.5%). Necrotic core volume was sig-
nificantly higher in the STR group than in the non-STR group (32.9  14.1 mm3 vs. 20.4  19.1 mm3, p 
0.05). Total plaque volume was similar in both groups. On receiver-operating characteristic analysis, necrotic
core volume clearly predicted STR after stent deployment as compared with fibrous, fibro-lipid, dense calcium,
and total plaque volumes. The necrotic core volume that was best predictive for STR was 33.4 mm3, with a sen-
sitivity of 81.7% and a specificity of 63.6%.
Conclusions Virtual Histology IVUS is a useful means of predicting the risk of distal embolization after primary stent deploy-
ment in patients with STEMI. (J Am Coll Cardiol 2007;50:1641–6) © 2007 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.06.051d
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Srimary stent implantation is an important option in the
reatment of patients with ST-segment elevation myocardial
nfarction (STEMI) (1). However, distal embolization was
ound in 9% to 15% of patients who underwent primary
ercutaneous coronary intervention (PCI) for STEMI (2,3).
See page 1647
t is well known that distal embolization is associated with
oor functional recovery and adverse outcomes (4). A
revious study reported that distal embolization during
ngioplasty for acute myocardial infarction was associated
ith an 8-fold increase in 5-year mortality (3). High-
ressure stent deployment is considered a major cause of
rom the Division of Cardiology, Gunma Prefectural Cardiovascular Center, Mae-
ashi, Gunma, Japan.t
Manuscript received March 12, 2007; revised manuscript received May 29, 2007,
ccepted June 4, 2007.istal embolization induced by liberated plaque debris dur-
ng primary angioplasty (1). However, the plaque composi-
ion that leads to distal embolization after stent deployment
s yet to be determined.
Virtual Histology intravascular ultrasound (VH-IVUS)
Volcano Therapeutics, Inc., Rancho Cordova, California)
as recently become available for routine clinical use. It uses
pectral analysis of radiofrequency ultrasound signals to
nable detailed assessment of plaque composition. In this
tudy, we aimed to evaluate the composition of culprit
laque in STEMI by VH-IVUS and to predict the risk of
istal embolization of plaque after primary stent deployment
n patients with STEMI.
ethods
tudy protocol and patient enrollment. In this prospec-
ive, single-center study, 71 patients with de novo STEMI
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to December 2006. The inclu-
sion criteria were as follows: 1)
presentation within 12 h of
symptom onset; 2) chest pain
lasting 30 min and resistant to
nitrates; 3) 0.2 mV ST-
segment elevation in at least 2
contiguous leads on 12-lead
electrocardiography (ECG); 4)
an infarct-related native artery
with a reference lumen diame-
ter 2.5 mm by visual estima-
tion that was deemed suitable
for stent placement; and 5) by
IVUS, coronary artery occlusion
or sub-occlusion (Thrombolysis In
Myocardial Infarction [TIMI]
flow grade II on diagnostic an-
giography). Left main trunk artery
lesions were excluded.
All the patients gave written informed consent for all
rocedures and our institutional review board approved this
esearch.
rimary PCI and IVUS procedure. Immediately after
he angiography, the culprit lesion was crossed with a
onventional guidewire. An aspiration catheter was ad-
anced over the guidewire, and the lesion was aspirated.
fter thrombectomy, intracoronary nitroglycerin (0.1 to
.2 mg) was administered and TIMI II or III coronary
ow was confirmed angiographically. A 20-MHz, 3.2-F
hased-array IVUS catheter (Eagle Eye, Volcano Ther-
peutics) was placed distal to the lesion, and it was pulled
ack at 0.5 cm/s to the proximal part of the lesion with
n auto-motorized pullback system. Stent deployment
as performed immediately after IVUS.
The corrected TIMI frame count (CTFC) immediately
fter stent deployment was estimated in the infarct-related
rtery as previously reported (5). Assessment for the CTFC
as performed separately by 2 independent observers un-
ware of the IVUS findings. During PCI, heparin sodium
as administered to maintain the activated clotting time at
50 to 300 s.
VUS data analysis. The VH-IVUS data were recorded
nto the imaging system hard disk, and analyses were
ndependently performed by experienced analysts who were
naware of the angiographic findings and baseline clinical
nd lesion characteristics. All measurements were automat-
cally derived from Volcano Invision Gold imaging system
oftware. Lumen and media areas were measured. Plaque
rea was calculated as the difference between media area and
umen area. The VH-IVUS data analysis was based on gray
cale border contour calculation, and the tissue maps were
rovided by the software (green  fibrous, yellow 
bro-lipid, red  necrotic core, and white  dense cal-
Abbreviations
and Acronyms
CTFC  corrected
Thrombolysis In Myocardial
Infarction frame count
ECG  electrocardiography
IVUS  intravascular
ultrasound
PCI  percutaneous
coronary intervention
ROC  receiver-operating
characteristic
STEMI  ST-segment
elevation myocardial
infarction
STR  ST-segment
re-elevation
TIMI  Thrombolysis In
Myocardial Infarction
VH  Virtual Histologyium). Volumes were automatically determined by the Loftware, a summation of measured cross-sectional areas in
ll frames of the pullback region based on Simpson’s rule.
he individual percentages of plaque components in the
otal plaque volume were calculated.
CG analysis. Twelve-lead ECGs were continuously re-
orded during the procedure and assessed before the throm-
ectomy, just before and immediately after stent deploy-
ent. The ST-segment elevation was measured 20 ms after
he J point. The ST-segment score was calculated as the
um of ST-segment elevation 0.1 mV for leads V1 to V6,
, II, and aVL in anterior infarction and for leads II, III,
VF, V5, and V6 in inferior infarction. In true posterior
nfarction, reciprocal ST-segment depressions 0.1 mV in
1 and V2 were also included. The ST-segment scores
efore and after stent deployment were compared to evalu-
te distal embolization induced by stent deployment. Sig-
ificant ST-segment re-elevation (STR) was defined as
ncrease in ST-segment score of 2 mm immediately after
tent deployment.
tatistical analysis. Quantitative variables are presented as
ean  SD and categorical variables as percentages. Con-
inuous variables were compared with the Student t test and
ategorical data with the Fisher’s exact or chi-square tests, as
ppropriate. Correlation between total plaque volume and
ach plaque composition was evaluated by using linear
egression models. Receiver-operating characteristic (ROC)
nalysis was used to determine the optimal cut-off value for
ach plaque component volume for the prediction of STR
fter stent deployment. The cut-off point was defined as the
reatest sum of the sensitivity and specificity estimates. The
rea under the ROC curve (AUC) was used as a measure of
est accuracy. All statistical analyses were performed with
MP 4.0.5J software (SAS Institute Inc., Cary, North
arolina). All p values 0.05 were considered statistically
ignificant.
esults
aseline clinical characteristics. The target vessels were
he left anterior descending artery (39 cases), left circumflex
rtery (16 cases), and right coronary artery (16 cases).
rimary stenting was successful in all patients. The mean
ge was 64  12 years. Baseline patient characteristics are
hown in Table 1.
H-IVUS analysis. A total of 71 coronary lesions under-
ent VH-IVUS analysis. The mean total plaque volume
aseline Patient Characteristics
Table 1 Baseline Patient Characteristics
Age (yrs) 64 12
Gender (male/female) 50/21
Infarct-related artery (LAD/LCX/RCA) 39/16/16
Systemic hypertension (%) 45 (63.4)
Hypercholesterolemia (%) 29 (40.8)
Diabetes mellitus (%) 28 (39.4)
Current smoking (%) 33 (46.5)AD  left anterior descending artery; LCX  left circumflex artery; RCA  right coronary artery.
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October 23, 2007:1641–6 Virtual Histology for STEMIas 113.0  67.3 mm3. The mean percentages of fibrosis,
bro-lipid, necrotic core, and dense calcium volumes were
3.0  9.1%, 11.5  6.9%, 18.8  8.6%, and 6.6  5.1%,
espectively. A strong positive correlation was found be-
ween total plaque volume and percentage of dense calcium
r 0.74, p 0.0001). A negative correlation between total
laque volume and percentage of fibrosis was found (r 
0.53, p  0.0001); however, there were no correlations
etween total plaque volume and percentage of necrotic core
r fibro-lipid (Fig. 1).
TR, CTFC, and plaque composition. Mean ST-
egment elevation scores were 11.0  9.5 before stent
eployment and 9.8  8.6 afterward. An STR immediately
fter stent deployment was observed in 11 patients (15.5%).
he necrotic core volume was significantly higher in the
TR group compared with the non-STR group (32.9 
4.1 mm3 vs. 20.4  19.1 mm3, p  0.0439). However,
here was no difference in total plaque volume, fibrous
olume, fibro-lipid volume, and dense calcium volume
etween the 2 groups. Lesion length, vessel diameter, and
umen diameter also showed no differences between the 2
roups. The CTFC was significantly higher in the STR
roup than in the non-STR group (37.5  16.6 vs. 21.2 
.8, p  0.0001). Infarct-related artery showed no differ-
nces between the 2 groups (Table 2). The STR group
ontained a significantly higher number of patients with
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Figure 1 Correlation Between Total Plaque Volume and Each P
A strong positive correlation was found between total plaque volume and percenta
volume and percentage of fibrosis was found; however, there were no correlationsyperlipidemia (STR group vs. non-STR group  81.8%
s. 45.0%, p  0.0457) and a smaller number of patients
ith diabetes (STR group vs. non-STR group  9.1% vs.
1.7%, p  0.0463). There was no difference in the
umber of patients with hypertension (STR group vs.
on-STR group  81.8% vs. 68.3%, p  0.4877), current
moking (STR group vs. non-STR group  45.5% vs.
6.7%, p  0.5274), body mass index (STR group vs.
on-STR group  22.9  3.0 kg/m2 vs. 23.9  3.4
g/m2, p  0.3702), and time from symptoms to PCI
STR group vs. non-STR group  6.7  2.3 h vs. 5.7 
.7 h, p  0.2417) between the STR group and the
on-STR group.
OC analysis of plaque composition volume for predic-
ion of STR after stent deployment. We performed ROC
nalysis of the plaque composition volume (Fig. 2). Necrotic
ore volume clearly predicted STR after stent deployment
ompared with fibrous, fibro-lipid, dense calcium, and total
laque volume. The AUC in ROC analysis of necrotic core
olume was 0.756 and highest among the analyzed variables.
he best cut-off value of necrotic core volume for prediction
f STR was 33.4 mm3, with a sensitivity of 81.7% and a
pecificity of 63.6%. Necrotic core volume 33.4 mm3 was
bserved in 26.8% of all the patients. The VH-IVUS image
xamples of STR case and non-STR case are shown in
igure 3.
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his is the first trial specifically designed to evaluate the
fficacy of VH-IVUS in predicting the risk of distal embo-
ization during primary PCI in patients with STEMI. The
ajor novel findings in the present study were as follows: 1)
high necrotic core volume shown by VH-IVUS is predic-
ive of distal embolization as assessed by STR after stent
eployment; 2) the best cut-off value of necrotic core
olume for prediction of distal embolization was 33.4 mm3,
ith a sensitivity of 81.7% and a specificity of 63.6%; and 3)
otal plaque volume was not related to distal embolization
fter primary stent deployment.
Liberation of plaque debris by iatrogenic plaque disrup-
ion is a mechanism of distal embolization during primary
CI (6). An STR during PCI and a higher CTFC are
ecognized as predictors of the no-reflow phenomenon
5,7). In the no-reflow cases, distal embolization of plaque
r thrombus from the lesion site is the likely mechanism (7).
n the basis of these findings, we adopted the STR as an index
f distal embolization, although STR after stent deployment
ight be caused by microvascular dysfunction induced by
arious mechanisms (8–10). However, in this study, stent
eployment was performed after thrombectomy and coronary
ow (TIMI II or III) was observed before stent deployment in
ll cases. Therefore, distal embolization of plaque or thrombus
rom the lesion site induced by stent deployment is the
robable cause of STR. In addition, STR after thrombectomy
as observed in 13 patients. Of these patients, STR after stent
eployment was observed in 1 patient. These data suggest that
TR after stent deployment is not attributable to thrombec-
omparison Between STR Group and Non-STR Group
Table 2 Comparison Between STR Group and Non-STR Group
STR Group
(n  11)
Non-STR
Group
(n  60) p Value
Infarct-related artery 0.5083
LAD (%) 7 (63.6) 32 (53.3)
LCX (%) 3 (27.3) 13 (21.7)
RCA (%) 1 (9.1) 15 (25.0)
ST-segment score
Pre-thrombectomy 18.4 11.9 15.1 10.7 0.3621
Pre-stent deployment 10.7 7.6 11.1 9.9 0.9061
Post-stent deployment 18.0 8.4 8.3 7.8 0.0004
CTFC after stent deployment 37.5 16.6 21.2 5.8 0.0001
IVUS measurements
Total plaque volume (mm3) 122.0 57.5 111.4 69.2 0.6355
Fibrosis (mm3) 67.1 30.7 68.2 35.3 0.9204
Fibro-lipid (mm3) 9.8 10.4 13.2 11.4 0.368
Necrotic core (mm3) 32.9 14.1 20.4 19.2 0.0439
Dense calcium (mm3) 12.2 8.6 9.6 13.9 0.5585
Mean vessel diameter (mm) 4.0 0.4 4.4 0.7 0.1244
Mean lumen diameter (mm) 2.3 0.2 2.4 0.2 0.0732
Lesion length (mm) 17.2 5.1 15.2 8.7 0.4742
TFC  corrected Thrombolysis In Myocardial Infarction frame count; IVUS  intravascular
ltrasound; STR  ST-segment re-elevation; other abbreviations as in Table 1.omy but to stent deployment.Although some previous studies have shown that the
oronary aspiration improves myocardial reperfusion in
atients with STEMI (11–13), the issue of mechanical
iberation of plaque debris induced by stent deployment
emains unresolved. Moreover, it is still unclear which
haracteristics of the plaque cause distal embolization after
tent deployment. Previous studies showed that a greater
therosclerotic plaque burden was correlated with distal
mbolization in patients with stable or unstable angina
ectoris (14,15). In our results, however, total plaque
olume was unrelated; moreover, it was found that necrotic
ore volume was the strong risk factor for distal emboliza-
ion. This conflicting finding might depend on the differ-
nces in plaque characteristics, because acute coronary
yndromes are usually caused by rupture or erosion of
brous caps covering the lipid-rich necrotic cores of vulner-
ble and usually small-sized plaques (16,17). We demon-
trated a correlation between total plaque volume and the
ercentage of dense calcium (r  0.74, p  0.0001) and of
brosis (r  0.53, p  0.0001), although there was no
orrelation between the percentage of necrotic core and total
laque volume. These findings suggest that even if a small
ized plaque is observed after thrombectomy in STEMI, the
isk of distal embolization is not low.
Figure 2 Receiver-Operating Characteristic
Analysis of the Plaque Component Volume and STR
Prognostic value of plaque composition volume in predicting ST-segment re-
elevation (STR) after stent deployment is shown in the table. AUC  area
under the curve; CI  confidence interval.
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October 23, 2007:1641–6 Virtual Histology for STEMIAlthough no difference was observed in dense calcium
olume between STR group and non-STR group, no
ignificant difference was observed between AUC for dense
alcium volume (0.664) and that for the necrotic core
olume (0.756) in the ROC analysis of the plaque compo-
ent volume and STR (p  0.4024). In addition, a strong
ositive correlation (r  0.81, p  0.0001) was observed
etween the necrotic core volume and dense calcium vol-
mes in the present study. These findings might suggest
hat dense calcium is also concerned in STR after stent
eployment. Moreover, because our observations are pre-
iminary, extensive additional validation might be required.
Various embolic protection devices are now available, and
isible debris that otherwise would have entered the distal
irculation can be removed in patients with STEMI (18).
lthough routine use of embolic protection devices in
atients with STEMI cannot be advocated (18,19), they are
xpected to be effective in decreasing myocardial damage in
elected patients at high risk of distal embolization.
linical implications. In the present study, the major
redictor of distal embolization induced by stent deploy-
ent was necrotic core volume determined by VH-IVUS.
he best cut-off value was 33.4 mm3, with a sensitivity of
1.7% and a specificity of 63.6%. Embolic protection
evices are expected to be effective in these carefully selected
TEMI patients with high risk of distal embolization.
tudy limitations. Although VH-IVUS has been validated
fibrous: 73.8 %
fibro-lipid: 14.8 %
Plaque area: 12.2 mm2 Lumen area: 3.7 mm2
Percentage of each plaque component at the MLA site
dense-calcium: 7.8 %
necrotic core: 3.5 %
dense-calcium: 12.2 %
necrotic core: 36.7 %fibrous: 46.0 %
fibro-lipid: 5.1 %
Plaque area: 9.8 mm2 Lumen area: 3.7 mm2
Percentage of each plaque component at the MLA site
Case B: STR case
distal
Case A: non-STR case
distal
Figure 3 Virtual Histology Intravascular Ultrasound Images of a
Immediately after the stent deployment, no electrocardiographic change and optim
observed in case A, although ST-segment re-elevation (STR) and delayed coronaryn human coronary arteries (20–23), recent data from a horcine model have shown that VH-IVUS was not accurate
n detecting the relative amounts of specific plaque compo-
ents compared with the corresponding histological speci-
ens (24). Thus, the necrotic core detected by VH-IVUS
ight not necessarily be a pathological one. However, the
im of this study was to identify the relationship between
H-IVUS data and distal embolization, and no mention is
ade of pathological plaque composition. Moreover, even
hough all the patients underwent thrombectomy via an
spiration catheter, the presence of residual thrombus in
ulprit lesions might have confounded the results for plaque
omponent assessment. A glycoprotein IIb/IIIa inhibitor
as not used in the present study, because of its unavail-
bility in our country. In addition, because clopidogrel still
as an off-label use for patients with STEMI in our country,
one of the patients were given clopidogrel in this study.
astly, we need to prospectively validate our measurements
n another cohort to see how the predictive algorithm
orrelates with STR.
onclusions
irtual Histology IVUS is a useful means of predicting the
isk of distal embolization after primary stent deployment in
atients with STEMI.
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